Elucida Oncology
is a New Jersey-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read moreElucida Oncology
is a New Jersey-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
Oct 26, 2024
Endpoints News
Elucida Oncology: Elucida Oncology shutters due to 'lack of funding'
Feb 15, 2024
Benzinga
Elucida Oncology: Elucida Oncology to Present at the Evercore ISI 2024 Emerging Biotech Conference
Feb 15, 2024
Benzinga
Elucida Oncology: Elucida Oncology to Present at the Evercore ISI 2024 Emerging Biotech Conference
Sep 11, 2023
GlobeNewswire
Press Release: Elucida Oncology : Elucida Oncology Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023
Aug 24, 2023
Benzinga
Elucida Oncology: Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer
Jul 20, 2023
GlobalNewswire
Press Release: Elucida Oncology : Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial
Jun 23, 2023
Endpoints News
Elucida Oncology: Elucida Oncology nabs more funds for its take on ADCs, sees potential in radiotherapy partnership
May 24, 2023
sec
Elucida Oncology: Elucida Oncology Received $22.9M in Equity Funding
Apr 21, 2023
Clinical Trials Arena
Elucida Oncology: Elucida unveils positive safety data from Phase I trial of ELU001
Apr 11, 2023
Life Care News
Elucida Oncology: Elucida Oncology to Present New Clinical and Preclinical
Elucida Oncology Competitors
1
2
3
4
5
6
7
8
9
10